Etoperidone
From Wikipedia, the free encyclopedia
 |
|
|
Etoperidone
|
|
| Systematic (IUPAC) name | |
| 2-[3-[4-(3-chlorophenyl)piperazin-1-yl] propyl]-4,5-diethyl-1,2,4-triazol-3-one |
|
| Identifiers | |
| CAS number | |
| ATC code | N06 |
| PubChem | |
| Chemical data | |
| Formula | C19H28ClN5O |
| Mol. mass | 377.911 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Etoperidone (1-(3-Chlorophenyl)-4-(3-chloropropyl) piperazine HCI), an atypical antidepressant, is a 5-HT2 receptor antagonist[1] similar in molecular structure to trazodone. In the 1970's it was a popular drug used to impede the effects of LSD.
 |
This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
